Morton Salt Co. v. G. S. Suppiger Co.

314 U.S. 488, 62 S. Ct. 402, 86 L. Ed. 363, 1942 U.S. LEXIS 1242
CourtSupreme Court of the United States
DecidedFebruary 2, 1942
Docket49
StatusPublished
Cited by474 cases

This text of 314 U.S. 488 (Morton Salt Co. v. G. S. Suppiger Co.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Morton Salt Co. v. G. S. Suppiger Co., 314 U.S. 488, 62 S. Ct. 402, 86 L. Ed. 363, 1942 U.S. LEXIS 1242 (1942).

Opinion

Mr. Chief Justice Stone

delivered the opinion of the Court.

Respondent brought this suit in the district court for an injunction and an accounting for infringement of its Patent No. 2,060,645, of November 10, 1936, on a machine for depositing salt tablets, a device said to be useful in the canning industry for adding predetermined amounts of salt in tablet form to the contents of the cans.

Upon petitioner’s motion, pursuant to Rule 56 of the Rules of Civil Procedure, the trial court, without passing *490 on the issues of validity and infringement, granted summary judgment dismissing the complaint. It took the ground that respondent was making use of the patent to restrain the sale of salt tablets in competition with its own sale of unpatented tablets, by requiring licensees to use with the patented machines only tablets sold by re* spondent. The Court of Appeals for the Seventh Circuit reversed, 117 F. 2d 968, because it thought that respondent’s use of the patent was not shown to violate § 3 of the Clayton Act, 15 U. S. C. § 14, as it did not appear that the use of its patent substantially lessened competition or tended to create a monopoly in salt tablets. We granted certiorari, 313 U. S. 555, because of the public importance of the question presented and of an alleged conflict of the decision below with B. B. Chemical Co. v. Ellis, 117 F. 2d 829, and with the principles underlying the decisions in Carbice Corp. v. American Patents Corp., 283 U. S. 27, and Leitch Mfg. Co. v. Barber Co., 302 U. S. 458.

The Clayton Act authorizes those injured by violations tending to monopoly to maintain suit for treble damages and for an injunction in appropriate cases. 15 U. S. C. § § 1, 2, 14, 15, 26. But the present suit is for infringement of a patent. The question we must decide is not necessarily whether respondent has violated the Clayton Act, but whether a court of equity will lend its aid to protect the patent monopoly when respondent is using it as the effective means of restraining competition with its sale of an unpatented article.

Both respondent’s wholly owned subsidiary and the petitioner manufacture and sell salt tablets used and useful in the canning trade. The tablets have a particular configuration rendering them capable of convenient use in respondent’s patented machines. Petitioner makes and leases to canners unpatented salt depositing machines, *491 charged to infringe respondent’s patent. Eor reasons we indicate later, nothing turns on the fact that petitioner also competes with respondent in the sale of the tablets, and we may assume for purposes of this case that petitioner is doing no more than making and leasing the alleged infringing machines. The principal business of respondent’s subsidiary, from which its profits are derived, is the sale of salt tablets. In connection with this business, and as an adjunct to it, respondent leases its patented machines to commercial canners, some two-hundred in all, under licenses to use the machines upon condition and with the agreement of the licensees that only the subsidiary’s salt tablets be used with the leased machines.

It thus appears that respondent is making use of its patent monopoly to restrain competition in the marketing of unpatented articles, salt tablets, for use with the patented machines, and is aiding in the creation of a limited monopoly in the tablets not within that granted by the patent. A patent operates to create and grant to the patentee an exclusive right to make, use and vend the particular device described and claimed in the patent. But a patent affords no immunity for a monopoly not within the grant, Interstate Circuit v. United States, 306 U. S. 208, 228, 230; Ethyl Gasoline Corp. v. United States, 309 U. S. 436, 456, and the use of it to suppress competition in the sale of an unpatented article may deprive the patentee of the aid of a court of equity to restrain an alleged infringement by one who is a competitor. It is the established rule that a patentee who has granted a license on condition that the patented invention be used by the licensee only with unpatented materials furnished by the licensor, may not restrain as a contributory in-fringer one who sells to the licensee like materials for like use. Motion Picture Patents Co. v. Universal Film Mfg. Co., 243 U. S. 502, 510; Carbice Corp. v. American Patents *492 Corp., supra; Leitch Mfg. Co. v. Barber Co., supra; cf. United Shoe Machinery Co. v. United States, 258 U. S. 451, 462; International Business Machines Corp. v. United States, 298 U. S. 131, 140.

The grant to the inventor of the special privilege of a patent monopoly carries out a public policy adopted by the Constitution and laws of the United States, “to promote the Progress of Science and useful Arts, by securing for limited Times to . . . Inventors the exclusive Right . . .” to their “new and useful” inventions. United States Constitution, Art. I, § 8, cl. 8; 35 U. S. C. § 31. But the public policy which includes inventions within the granted monopoly excludes from it all that is not embraced in the invention. It equally forbids the use of the patent to secure an exclusive right or limited monopoly not granted by the Patent Office and which it is contrary to public policy to grant.

It is a principle of general application that courts, and especially courts of equity, may appropriately withhold their aid where the plaintiff is using the right asserted contrary to the public interest. Virginian Ry. Co. v. Federation, 300 U. S. 515, 552; Central Kentucky Co. v. Railroad Commission, 290 U. S. 264, 270-73; Harrisonville v. Dickey Clay Co., 289 U. S. 334, 337-38; Beasley v. Texas & Pacific Ry. Co.,

Related

In Re Gabapentin Patent Litigation
648 F. Supp. 2d 641 (D. New Jersey, 2009)
Arista Records, Inc. v. Flea World, Inc.
356 F. Supp. 2d 411 (D. New Jersey, 2005)
Association of American Medical Colleges v. Princeton Review, Inc.
332 F. Supp. 2d 11 (District of Columbia, 2004)
Metro-Goldwyn-Mayer Studios Inc. v. Grokster, Ltd.
269 F. Supp. 2d 1213 (C.D. California, 2003)
Video Pipeline, Inc. v. Buena Vista Home Entertainment, Inc.
192 F. Supp. 2d 321 (D. New Jersey, 2002)
Agere Systems Guardian Corp. v. Proxim, Inc.
190 F. Supp. 2d 726 (D. Delaware, 2002)
Healthpoint, Ltd. v. Ethex Corp.
273 F. Supp. 2d 817 (W.D. Texas, 2001)
Hoffman-La Roche Inc. v. Genpharm Inc.
50 F. Supp. 2d 367 (D. New Jersey, 1999)
Hunter Douglas, Inc. v. Comfortex Corp.
44 F. Supp. 2d 145 (N.D. New York, 1999)
Zeneca Ltd. v. Pharmachemie B.V.
37 F. Supp. 2d 85 (D. Massachusetts, 1999)
Basic Books, Inc. v. Kinko's Graphics Corp.
758 F. Supp. 1522 (S.D. New York, 1991)
Windsurfing International, Inc. v. Fred Ostermann GmbH
613 F. Supp. 933 (S.D. New York, 1985)
Rick v. Buchansky
609 F. Supp. 1522 (S.D. New York, 1985)
Transitron Electronic Corp. v. Hughes Aircraft Co.
487 F. Supp. 885 (D. Massachusetts, 1980)
Skil Corp. v. Lucerne Products, Inc.
489 F. Supp. 1129 (N.D. Ohio, 1980)
Orth-O-Vision, Inc. v. Home Box Office
474 F. Supp. 672 (S.D. New York, 1979)
American Dietaids Co., Inc. v. Plus Products
412 F. Supp. 691 (S.D. New York, 1976)
Krampe v. Ideal Industries, Inc.
347 F. Supp. 1384 (N.D. Illinois, 1972)
Gates Learjet Corp. v. Magnasync Craig Corp.
339 F. Supp. 587 (D. Colorado, 1972)

Cite This Page — Counsel Stack

Bluebook (online)
314 U.S. 488, 62 S. Ct. 402, 86 L. Ed. 363, 1942 U.S. LEXIS 1242, Counsel Stack Legal Research, https://law.counselstack.com/opinion/morton-salt-co-v-g-s-suppiger-co-scotus-1942.